Solid Biosciences (SLDB) Depreciation and Depletion (2017 - 2023)

Solid Biosciences has disclosed Depreciation and Depletion across 7 years of filings, most recently posting $587000.0 for Q4 2023.

• Depreciation and Depletion for Q4 2023 came in at $587000.0, up 8.91% year-over-year; the trailing twelve-month figure through Dec 2023 was $2.6 million (up 7.18% YoY), and the FY2023 annual result was $2.6 million, up 7.18% from the prior year.
• Depreciation and Depletion came in at $587000.0 for Q4 2023 at Solid Biosciences, roughly flat from $588000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $1.3 million in Q2 2020 to a low of $438000.0 in Q3 2022.
• The 5-year median for Depreciation and Depletion is $720000.0 (2021), against an average of $734950.0.
• Across the five-year window, Depreciation and Depletion soared 162.56% in 2019 and tumbled 46.18% in 2021, its largest moves.
• Solid Biosciences' Depreciation and Depletion stood at $806000.0 in 2019, then decreased by 1.24% to $796000.0 in 2020, then slipped by 4.52% to $760000.0 in 2021, then decreased by 29.08% to $539000.0 in 2022, then increased by 8.91% to $587000.0 in 2023.
• The last three Depreciation and Depletion figures came in at $587000.0 (Q4 2023), $588000.0 (Q3 2023), and $703000.0 (Q2 2023), per Business Quant data.